Jooss Karin, EVP and Head of Research and Development at Gritstone Oncology, holds 630.15K shares in Gritstone Oncology (Ticker: GRTS), holds 9.85K shares in Fate Therapeutics (Ticker: FATE).

See the Hottest Stocks Based on Insider Trading >

Jooss Karin
Gritstone Oncology (GRTS)
EVP and Head of Research and Development

Not Ranked

Jooss Karin has not reported sufficient informative transactions and therefore cannot be ranked.

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

97.93%

GRTS

2.07%

FATE

A breakdown of Jooss Karin's holdings

See the Top Stocks by Insiders

Insider Roles

Gritstone Oncology
(GRTS)

EVP and Head of Research and Development

Fate Therapeutics
(FATE)

Director

Roles that Jooss Karin holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Fate Therapeutics
(FATE)

Rating:Informative Sell

Date:Jun 06, 2022 - Jun 06, 2023

Return:+74.90%

The most profitable trade made by Jooss Karin

See the Latest Stocks Traded by Insiders

Jooss Karin's Trading History

GRTS

Gritstone Oncology

Feb 06, 2023

EVP and Head of Research and Development

Uninformative Buy

―

$1.05M

FATE

Fate Therapeutics

Jun 13, 2022

Director

Uninformative Buy

―

$22.06K

List of latest transactions for each holding click on a transaction to see Jooss Karin's performance on stock

See All Insider Trading from Today

Jooss Karin insider profile FAQ

What is the percentage of profitable transactions made by Jooss Karin?

The percentage of profitable transactions made by Jooss Karin is ―.

What is the average return per transaction made by Jooss Karin?

The average return per transaction made by Jooss Karin is ―.

What stocks does Jooss Karin hold?

Jooss Karin holds: GRTS, FATE stocks.

What was Jooss Karin’s latest transaction?

Jooss Karin latest transaction was an Uninformative Buy of ―.

What was Jooss Karin's most profitable transaction?

Jooss Karin’s most profitable transaction was an Informative Sell of FATE stock on June 6, 2022. The return on the trade was 74.90%.

What is Jooss Karin's role in Gritstone Oncology?

Jooss Karin's role in Gritstone Oncology is EVP and Head of Research and Development.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Jooss Karin Insider Profile

Jooss Karin Gritstone Oncology (GRTS)EVP and Head of Research and Development